Skip to main content

Mor George Adi's Form 4 filing

Chemomab Therapeutics Ltd.CMMB · filed Jun 1, 2026

Accession no.
0001178913-26-003004
Filed
Jun 1, 2026
Trade date
May 29, 2026
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions. Open-market purchases total $20.2K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mor George AdiCIK 0001851069Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 29, 2026American Depositary SharesPPurchaseDisposed−4,878$2.05−$9,999.9134,205Direct
May 29, 2026American Depositary SharesPPurchaseDisposed−4,926$2.08−$10,246.08139,131Direct
May 29, 2026American Depositary SharesJOtherDisposed−31,712–F1–31,712Direct
May 29, 2026American Depositary SharesJOtherDisposed−18,750–F1–18,750Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)